key: cord-0740722-t80p53y9 authors: Dadashi, Masoud; Dadashi, Ali; Sameni, Fatemeh; Sayadi, Shahram; Goudarzi, Mehdi; Nasiri, Mohammad Javad; Yaslianifard, Somayeh; Ghazi, Mona; Arjmand, Reza; Hajikhani, Bahareh title: SARS-CoV-2 and HIV co-infection; clinical features, diagnosis, and treatment strategies: A systematic review and meta-analysis date: 2022-05-19 journal: Gene Rep DOI: 10.1016/j.genrep.2022.101624 sha: db87cc90864742e5ed54a8b1b0485427f3afde76 doc_id: 740722 cord_uid: t80p53y9 BACKGROUND AND AIM: Coronavirus disease 2019 (COVID-19) in people living with human immunodeficiency virus (HIV) who has a compromised immune system can be associated with more significant risks for severe complications. To date, no comprehensive study has been performed to evaluate HIV in patients with COVID-19. In the present study, we assessed the status of patients co-infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and HIV as a systematic review and meta-analysis. METHODS: A systematic literature search strategy was conducted via reviewing original research articles published in Medline, Web of Science, and Embase databases in 2019 and 2020. Statistical analysis was performed using STATA software, version 14.0 (Stata Corporation, College Station, Texas, USA), to report the prevalence of HIV among patients with COVID-19. Case reports/case series were also evaluated as a systematic review. RESULTS: Sixty-three studies (53 case reports/case series and ten prevalence studies) were included in our study. A meta-analysis of prevalence studies showed that HIV infection among patients with COVID-19 was reported in 6 countries (Uganda, China, Iran, USA, Italy, and Spain) with an overall frequency of 1.2% [(95% CI) 0.8–1.7] among 14,424 COVID-19 patients. According to the case reports and case series, 111 patients with HIV have been reported among 113 patients with COVID-19 from 19 countries. Most of the cases were in the USA, China, Italy, and Spain. CONCLUSION: The small number of SARS-CoV-2-HIV co-infected patients reported in the literature makes it difficult to draw precise conclusions. However, since people with HIV are more likely to develop more severe complications of COVID-19, targeted policies to address this raised risk in the current pandemic should be considered. Our findings highlight the importance of identifying underlying diseases, co-infections, co-morbidities, laboratory findings, and beneficial treatment strategies for HIV patients during the COVID-19 pandemic. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the responsible agent of the current coronavirus disease 2019 pandemic, emerged in China in December 2019 and has so far been reported from all around the world (1) . The World Health Organization (WHO) lists it as the sixth public health emergency worldwide (2) . Although many people with the infection are asymptomatic or show mild symptoms, many patients develop the severe form of the disease, leading to severe complications or even death (3, 4) . The proper response of the host to COVID-19 depends on the activation of both innate and acquired immunity. For this reason, there is a significant concern about the vulnerability of immunodeficient patients before or during the COVID-19 pandemic (5, 6) . Immunodeficiency is a disorder of the immune system in which the host body is disabling to establish effective immune responses to various infections (7, 8) . As a result, such people are prone to more intense forms of infection (9) . Since the Centers for Disease Control and Prevention (CDC) has identified immunocompromised patients as a high-risk group for severe forms of new coronavirus infection, it is essential to conduct studies to determine the relationship between human immunodeficiency virus (HIV) infection and the severity of COVID-19 (9) (10) (11) . However, there are limited data regarding the clinical impact of COVID-19 on people infected with HIV. In fact, since there is a J o u r n a l P r e -p r o o f significant relationship between immunodeficiency the and severity of COVID-19 (12) , it may be possible to reduce the severe complications and mortality due to the infection in this group of patients by using appropriate immunomodulators (13, 14) As far as we know, a comprehensive study has not yet evaluated the status of patients who suffer from HIV and COVID-19 at the same time. Hence, the purpose of the current study was to assess the status of patients who had concurrent COVID-19 and HIV as a systematic review and meta-analysis. In each study, the following items were considered: the first author's last name, time of the study, time of publication, region, number of COVID-19 patients, number of COVID-19 patients with HIV, clinical symptoms, laboratory findings, outcomes, diagnostic methods, and treatment. The data were obtained by two independent individuals and verified by another researcher. The meta-analysis of prevalence studies showed that the frequency of HIV among patients with COVID-19 was 2.4% (95% CI 0.5-4.2) among 2739 patients in America, 1.3% (95% CI 0.6-2.1) among 7586 patients in Europe, and 0.9% (95% CI 0.3-1.4) among 4043 patients in Asia (Table 3 ). There were no data on HIV infection prevalence among COVID-19 patients from Oceania. As shown in Table 1 , the most COVID-19 patients with HIV were reported in Europe (Italy and Spain with 31 and 58 cases, respectively). We assessed the HIV infection among cases with COVID-19, which was reported in the mentioned electronic databases. Characteristics of case reports/case series studies (which were not taken into account during the analyses as mentioned above) are shown in Table 2 Table 5 as "others". As it turns out, HCQ (in 18 studies), enoxaparin (in 5 studies), methylprednisolone, atorvastatin, and prednisolone (3 studies for each) were other drug combinations that were used more than others in the treatment of patients. COVID-19, which emerged in late 2019, has infected more than 60 million people globally and has caused many deaths in various countries (15, 16 . Despite numerous efforts to control the COVID-19 pandemic, the disease remains a significant challenge to the global community and a threat to public health. Although much research has been done to combat COVID-19 worldwide, there is no definitive cure. Nevertheless, supportive treatments such as fever-reducing steps, oxygen therapy to alleviate the respiratory problems of patients, rest at home, and drinking fluids in the early stages of the disease may be beneficial. According to the analysis performed in the present study, the most antiviral drugs Unfortunately, there is inadequate information about the effectiveness of the drugs listed in Table 5 . So, the exact efficiency of these agents in the management of patients cannot be determined. Another point to note is the death rate in patients with COVID19-HIV, which seems to be high according to the findings of the current report (17.1%). However, other confounding factors may influence this result, such as patients' old age or underlying diseases. Several underlying diseases and old age were common among patients who died because of COVID-19 whose personal data were recorded. It is also noteworthy that only patients referred to the hospital were assessed in selected studies, so this may be another factor that would have impacted the death rate, which is higher than in the general population. Some studies revealed no sufficient evidence showing a varying disease course or higher COVID-19 infection or even death rates in HIV-infected people compared to non-infected ones (42, 43 infections. As a result, we have not been able to analyze them and explore in-depth the exact mechanisms by which they work and their impact on the recovery process of patients with COVID19-HIV. A pneumonia outbreak associated with a new coronavirus of probable bat origin A new coronavirus associated with human respiratory disease in China Hospitalization rates and characteristics of patients hospitalized with laboratoryconfirmed coronavirus disease 2019-COVID-NET, 14 States COVID-19 and Skin Manifestations: An Overview of Case Reports/Case Series and Meta-Analysis of Prevalence Studies. Frontiers in medicine SARS-CoV-2 Receptor ACE2 Is Enriched in a Subpopulation of Mouse Tongue Epithelial Cells in Nongustatory Papillae but Not in Taste Buds or Embryonic Oral Epithelium Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. International journal of infectious diseases Overview of the immune response Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Systemic immunosuppression in times of COVID-19: Do we need to rethink our standards? Comparison of Estimated Excess Deaths in New York City during the COVID-19 and 1918 Influenza Pandemics Coronavirus infections and immune responses Immune deficiency is a risk factor for severe COVID-19 in people living with HIV Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19 COVID-19): strategic considerations for personalized therapeutic intervention Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control Pandemic flu: a comparative evaluation of clinical, laboratory, and radiographic findings in HIV-positive and negative children Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. The lancet HIV COVID-19 Among People Living with HIV: A Systematic Review COVID-19 in a Long-Term Care Facility High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients Bacterial infections and death among patients with Covid-19 versus non Covid-19 patients with pneumonia The microbial coinfection in COVID-19 Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients Whole-genome analysis of New Delhi Metallo-Beta-Lactamase-1-producing Acinetobacter haemolyticus from China Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Co-infections in people with COVID-19: a systematic review and meta-analysis COVID-19 Evaluation by Low-Dose High Resolution CT Scans Protocol Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms Lymphopenia in COVID-19: Therapeutic opportunities Functional exhaustion of antiviral lymphocytes in COVID-19 patients Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels Elevated D-Dimer Levels are Associated with Increased Risk of Mortality in COVID-19: A Systematic Review and Meta-Analysis Coagulation abnormalities and thrombosis in patients with COVID-19. The Lancet Haematology COVID-19 symptoms in HIV positive people similar to general population in Wuhan Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis COVID-19 in people living with HIV: A multicenter case-series study Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis Coronavirus Disease 2019 (COVID-19) in Italy Impact of COVID-19 on people living with HIV: a review Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses World Health O. Clinical management of severe acute respiratory infection when novel coronavirus ( 2019-nCoV) infection is suspected: interim guidance COVID-19 in an HIV-positive Kidney Transplant Recipient COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease Survival rate in hypertensive patients with COVID-19 Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study. Annals of the rheumatic diseases Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2 Clinical characteristics and outcomes in people living with human immunodeficiency virus hospitalized for coronavirus disease 2019 COVID-19 in patients with HIV: clinical case series HIV and SARS-CoV-2 coinfection: The diagnostic challenges of dual pandemics HIV and SARS-CoV-2 co-infection: A case report from Uganda Multi-organ failure after acute kidney injury in patient with HIV and COVID-19. New microbes and new infections COVID-19 in an HIV-infected patient. Lessons learned from an autopsy case COVID-19 associated with AIDS-related disseminated histoplasmosis: a case report Coronavirus Disease 2019 in an Orthotopic Liver Transplant Recipient Living with Human Immunodeficiency Virus COVID-19 pneumonia in an HIV-positive woman on antiretroviral therapy and undetectable viral load in Porto Alegre, Brazil. The Brazilian Journal of Infectious Diseases Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient Recovery from Triple Infection with Mycobacterium tuberculosis, HIV, and SARS-CoV-2 Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx COVID-19 crossing paths with AIDS in the homeless Four cases: Human immunodeficiency virus and novel coronavirus Co-infection in patients from Long Island Human Immunodeficiency Virus: A Dark Cloud With Silver Lining During the COVID-19 Pandemic Report: Coronavirus Disease and Pulmonary Tuberculosis in Patients with Human Immunodeficiency Virus: Report of Two Cases. The American journal of tropical medicine and hygiene A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Hospital-acquired SARS-CoV-2 pneumonia in a person living with HIV Predisposition or Protection? COVID-19 in a Patient on LVAD Support with HIV/AIDS. JACC: Case Reports SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States Clinical outcomes and prognosis of patients with HIV and SARS-CoV-2 coinfection Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV. Clinical Infectious Diseases A Study of Two Cases Co-Infected with SARS-CoV-2 and Human Immunodeficiency Virus Detection of blaOXA-23 and blaNDM-1 carbapenemase among clinical isolates of A. baumannii in Tabriz, north-west of Iran Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India Cases of coronavirus disease-2019 in HIVinfected transgender women The characteristics of two patients coinfected with SARS-CoV-2 and HIV in Wuhan Recovery from COVID-19 in two patients with coexisted HIV infection Journal of medical virology. 2020. 84. Sun LJ, Wong SXL, Gollamudi S. A Case of HIV and SARS-CoV-2 Co-infection in Singapore Computed tomography imaging of an HIV-infected patient with coronavirus disease 2019 (COVID-19) Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city Case Report: One Case of Coronavirus Desease Patient Co-nfected by HIV With a Low CD4+ T Cell Count Reply to Comments on'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city An HIV-infected patient with coronavirus disease 2019 has a favourable prognosis: a case report Pearls and pitfalls: Two contrasting HIV diagnoses in the COVID-19 era and the case for screening SARS-CoV-2 infection in a highly experienced person living with HIV Darunavir does not prevent SARS-CoV-2 infection in HIV patients HIV/SARS-CoV-2 coinfected patients in Istanbul COVID-19 in three people living with HIV in the United Kingdom Coinfection of severe acute respiratory syndrome coronavirus 2 and HIV in a teaching hospital: still much to learn People Living with HIV in the COVID-19 Era: A Case Report. AIDS research and human retroviruses Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus Coronavirus disease 2019 in patients with HIV in the province of Araba SARS-CoV-2 infection does not induce HIV viral escape in the central nervous system: A case series Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIVinfected patients? A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir The authors would like to thank Dr. Ali Hashemi, Department of Microbiology at Shahid Beheshti University of Medical Sciences, Tehran, Iran, for his sincere assistance and efforts to make this project happen.